RAPP   $25.9  -7.66% Market Closed

Rapport Therapeutics Inc
Total Cash 336.14M
totalCashPerShare 9.19
EBITDA -61.82M
Total Debt 1.82M
quickRatio 41.524
currentRatio 42.084
Total Revenue
debtToEquity 0.54
Revenue/Share
ROA
ROE
grossProfits
freeCashflow
operatingCashflow -49.75M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 734.81M
forwardPE -9.161184
floatShares 14.94M
sharesOutstanding 36.58M
sharesShort 1.84M
sharesShortPriorMonth 1.30M
dateShortInterest
sharesPercentSharesOut 0.05%
heldPercentInsiders 0.07%
heldPercentInstitutions 1.04%
Short Ratio help_outline 7.48%
shortPercentOfFloat 0.05%
impliedSharesOutstanding
bookValue 9.21
Price To Book help_outline 3.02
earningsQuarterlyGrowth
netIncomeToCommon -63.02M
trailingEps -1.72%
forwardEps -3.04%
enterpriseToEbitda -11.89
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.57 3Q 2024
institutionsCount 49
lastUpdated Oct. 17, 2024, 6:21 p.m.